Investors

Mauna Kea Technologies
Stock Information

Mauna Kea Technologies
Stock Information

Stay up to date on all our investor news

0,0911€

Last updated
09/11/2026 - 08:42

&

+0,11%

Events and Presentations

Financial Results

Governance 

News

Mauna Kea Technologies Announces the Launch of CellTolerance® at Cleveland Clinic Abu Dhabi, the First Hospital in the MENA Region to Offer the Program 

Mauna Kea Technologies Announces the Launch of CellTolerance® at Cleveland Clinic Abu Dhabi, the First Hospital in the MENA Region to Offer the Program 

Mauna Kea Technologies Reports Nine-Month 2026 Sales of €4.4 Million, Up 24% at Constant Exchange Rates 

Mauna Kea Technologies Reports Nine-Month 2026 Sales of €4.4 Million, Up 24% at Constant Exchange Rates 

Mauna Kea Technologies Announces 2026 Half-Year Results 

Mauna Kea Technologies Announces 2026 Half-Year Results 

No results found.

Shareholding Structure

Stock Information

IDENTIFICATION CODES

ISIN : FR0010609263

Ticker : ALMKT

ANALYST COVERAGE

ALLINVEST SECURITIES

Thibaut Voglimacci – Stephanopoli

EUROLAND CORPORATE
EUROLAND CORPORATE

Raphaël Génin

STATUTORY AUDITORS

• EY and Others, represented by Mr Franck SEBAG, 1-2 place des Saisons, 92400 Courbevoie- Paris La Défense, France

ANALYST REPORTS

View here